Literature DB >> 11696426

A novel strategy for human papillomavirus detection and genotyping with SybrGreen and molecular beacon polymerase chain reaction.

K Szuhai1, E Sandhaus, S M Kolkman-Uljee, M Lemaître, J C Truffert, R W Dirks, H J Tanke, G J Fleuren, E Schuuring, A K Raap.   

Abstract

Human papillomaviruses (HPVs) play an important role in the pathogenesis of cervical cancer. For identification of the large number of different HPV types found in (pre)malignant lesions, a robust methodology is needed that combines general HPV detection with HPV genotyping. We have developed for formaldehyde-fixed samples a strategy that, in a homogeneous, real-time fluorescence polymerase chain reaction (PCR)-based assay, accomplishes general HPV detection by SybrGreen reporting of HPV-DNA amplicons, and genotyping of seven prevalent HPV types (HPV-6, -11, -16, -18, -31, -33, -45) by real-time molecular beacon PCR. The false-positive rate of the HPV SybrGreen-PCR was 4%, making it well suited as a prescreening, general HPV detection technology. The type specificity of the seven selected HPV molecular beacons was 100% and double infections were readily identified. The multiplexing capacity of the HPV molecular beacon PCR was analyzed and up to three differently labeled molecular beacons could be used in one PCR reaction without observing cross talk. The inherent quantitation capacities of real-time fluorescence PCR allowed the determination of average HPV copy number per cell. We conclude that the HPV SybrGreen-PCR in combination with the HPV molecular beacon PCR provides a robust, sensitive, and quantitative general HPV detection and genotyping methodology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696426      PMCID: PMC1867051          DOI: 10.1016/S0002-9440(10)63012-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Homogeneous scoring of single-nucleotide polymorphisms: comparison of the 5'-nuclease TaqMan assay and Molecular Beacon probes.

Authors:  I Täpp; L Malmberg; E Rennel; M Wik; A C Syvänen
Journal:  Biotechniques       Date:  2000-04       Impact factor: 1.993

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

3.  Amplification with molecular beacon primers and reverse line blotting for the detection and typing of human papillomaviruses.

Authors:  J Z Jordens; S Lanham; M A Pickett; S Amarasekara; I Abeywickrema; P J Watt
Journal:  J Virol Methods       Date:  2000-09       Impact factor: 2.014

4.  Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas.

Authors:  M Frisch; R J Biggar
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

5.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Authors:  M L Gillison; W M Koch; R B Capone; M Spafford; W H Westra; L Wu; M L Zahurak; R W Daniel; M Viglione; D E Symer; K V Shah; D Sidransky
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

Review 6.  Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.

Authors:  H zur Hausen
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

7.  Single-tube real-time nested polymerase chain reaction for detecting human papillomavirus DNA.

Authors:  S Strauss; J Z Jordens; U Desselberger; J J Gray
Journal:  Diagn Mol Pathol       Date:  2000-09

Review 8.  Carcinoma of the anal canal.

Authors:  D P Ryan; C C Compton; R J Mayer
Journal:  N Engl J Med       Date:  2000-03-16       Impact factor: 91.245

9.  Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study.

Authors:  A M Josefsson; P K Magnusson; N Ylitalo; P Sørensen; P Qwarforth-Tubbin; P K Andersen; M Melbye; H O Adami; U B Gyllensten
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

10.  Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study.

Authors:  N Ylitalo; P Sørensen; A M Josefsson; P K Magnusson; P K Andersen; J Pontén; H O Adami; U B Gyllensten; M Melbye
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

View more
  5 in total

1.  Comparison of real-time PCR signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in archival cervical cancer tissue.

Authors:  Karin Biedermann; Nadia Dandachi; Maria Trattner; Georgia Vogl; Hildegard Doppelmayr; Elena Moré; Alfons Staudach; Otto Dietze; Cornelia Hauser-Kronberger
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  Molecular beacons: powerful tools for imaging RNA in living cells.

Authors:  Ricardo Monroy-Contreras; Luis Vaca
Journal:  J Nucleic Acids       Date:  2011-08-22

3.  Comparison of real-time polymerase chain reaction assay methods for detection of RHD gene in amniotic fluid.

Authors:  Tuba Gunel; Ibrahim Kalelıoglu; Yusuf Surmelı; Basak Turken; Hayri Ermıs; Kılıç Aydınlı
Journal:  J Nat Sci Biol Med       Date:  2011-07

4.  Comparing the Performance of Hybrid Capture II and Polymerase Chain Reaction (PCR) for the Identification of Cervical Dysplasia in the Screening and Diagnostic Settings.

Authors:  Hung N Luu; Karen Adler-Storthz; Laura M Dillon; Michele Follen; Michael E Scheurer
Journal:  Clin Med Insights Oncol       Date:  2013-09-25

5.  A novel arylbenzofuran induces cervical cancer cell apoptosis and G1/S arrest through ERK-mediated Cdk2/cyclin-A signaling pathway.

Authors:  Pinghong Ming; Ting Cai; Jin Li; Yong Ning; Shengao Xie; Tao Tao; Faqing Tang
Journal:  Oncotarget       Date:  2016-07-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.